Glucoamylase-modified yeast strains and methods for bioproduct production

Patent metadata

Field	Value
Publication number	US-10344288-B2
Application number	US-201615562266-A
Country	US
Kind code	B2
Filing date	Mar 25, 2016
Priority date	Mar 27, 2015
Publication date	Jul 9, 2019
Grant date	Jul 9, 2019

Abstract

Genetically engineered yeast with a heterologous glucoamylase and fermentation methods are described. The engineered yeast can have multiple exogenous nucleic acid sequences which each have a different sequence, but that encode the same or a similar glucoamylase protein that is heterologous to the yeast. The engineered yeast exhibit desirable bioproduct production profiles during a fermentation process. A fermentation medium with a starch material can be fermented with the engineered yeast to provide high ethanol titers, low glycerol titers, or both.

First claim

What is claimed is:

1. An engineered yeast comprising at least first, second, third, and fourth exogenous nucleic acids each comprising a sequence encoding a common glucoamylase polypeptide that is heterologous to the Saccharomyces species, or encoding two or more different glucoamylase polypeptides having 90% or greater sequence identity to each other, wherein the first, second, third, and fourth exogenous nucleic acids have nucleic acid sequences that are different from one another and wherein the first, second, third and fourth exogenous nucleic acid sequences are at least 90% identical to SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8.

2. The engineered yeast of claim 1 wherein the glucoamylase polypeptide(s) is from a yeast or fungal organism selected from the group consisting of Amorphotheca resinae, Aspergillus niger, Aspergillus awamori, Aspergillus oryzae, Aspergillus kawachii, Aspergillus shirousami, Blastobotrys adeninivorans, Candida albicans, Rhizopus oryzae, Schizosaccharomyces pombe , and Saccharomycopsis fibuligera.

3. The engineered yeast of claim 1 wherein the glucoamylase polypeptide has 90% or greater sequence identify to SEQ ID NO:11 and optionally includes one or more amino acid substitutions are at one or more of the following amino acid positions in SEQ ID NO:11: 1M-5T, 7F, 9T, 10A, 15V, 16A, 18C, 19V, 21V, 22E, 24D, 27N-30H, 32Q, 36G, 38T, 40A, 42S-50E, 52P, 53A, 56W, 64D, 71K-74K, 77V, 79V, 86E, 90F, 97T, 103S-106A, 108V, 111H, 112S, 114S, 121V, 127S-129T, 131T, 135V, 141N, 144S, 145P, 148D, 157V, 159D, 160T, 164A, 165S, 187A, 189A-191H, 193N, 197L, 199A-203G, 205P, 206Y, 209A, 210S, 214W, 215K, 222Q, 223H, 225S-227H, 229S-231S, 242T, 247A, 251L, 255S, 257G-2615, 263T-265N, 267P, 268P, 270T-272W, 274E-270A, 281N, 284I-286S, 292S-295K, 300S, 302Q, 304S, 307G, 316A, 317A, 3191, 325D-329Y, 333N, 337S, 341N, 343L, 345Y, 348V, 352N, 355K, 3561, 358G, 359N, 361K, 366V, 377V, 379T, 386Q, 393, G, 395T, 396F, 398T, 402N-411V, 413E, 415L, 419L, 420Y, 422S, 423F, 425A, 429K, 431D, 433S, 435A, 437K, 440L, 442L-444Y, 448N-451N, 453I-455S, 457L, 458Q, 465K, 467L, 472D, 474N, 476Q, 478T, 480E, 481I, 487F-489A, 492V, 500S, 503S, 505N, 507A, 511L-513E, and 515L.

4. The engineered yeast of claim 1 wherein the glucoamylase polypeptide comprises a secretion signal amino acid sequence having 90% or greater identity to SEQ ID NO:12 or SEQ ID NO:13.

5. The engineered yeast of claim 4 wherein the glucoamylase polypeptide comprises a secretion signal amino acid sequence of SEQ ID NO:12 or SEQ ID NO:13.

6. The engineered yeast of claim 1 wherein the first, second, third, and fourth exogenous nucleic acids differ from each other by at least 10%.

7. The engineered yeast of claim 1 wherein the first nucleic acid comprises a nucleic acid having 95% or greater, 98% or greater, 99% or greater, or 100% identity to SEQ ID NO:5.

8. The engineered yeast of claim 1 wherein the second nucleic acid comprises a nucleic acid having 95% or greater, 98% or greater, 99% or greater, or 100% identity to SEQ ID NO:6.

9. The engineered yeast of claim 1 wherein the third nucleic acid comprises a nucleic acid having 95% or greater, 98% or greater, 99% or greater, or 100% identity to SEQ ID NO:7.

10. The engineered yeast of claim 1 wherein the fourth nucleic acid comprises a nucleic acid having 95% or greater, 98% or greater, 99% or greater, or 100% identity to SEQ ID NO:8.

11. The engineered yeast of claim 1 wherein the first and third nucleic acids are under the control of a first common promoter.

12. The engineered yeast of claim 11 , wherein the first common promoter comprises a glyceraldehyde-3-phosphate dehydrogenase (TDH3) promoter nucleic acid sequence.

13. The engineered yeast of claim 1 wherein the second and fourth nucleic acids are under the control of a second common promoter.

14. The engineered yeast of claim 13 wherein the second common promoter comprises a phosphoglycerate kinase (PGK) promoter nucleic acid sequence.

15. The engineered yeast of claim 1 selected from the group consisting of Saccharomyces cerevisiae, Isaatchenkia orientalis, Candida utilis, Pichia Stipitis, Yarrowia lipolytica, Kluyveromyces marxiannus , and Kluyeromyces lactis.

16. An engineered yeast comprising first, second, third, and fourth exogenous nucleic acids each comprising a sequence encoding a polypeptide comprising SEQ ID NO:11, wherein the first nucleic acid comprises SEQ ID NO:5, the second nucleic acid comprises SEQ ID NO:6, the third nucleic acid comprises SEQ ID NO:7, and the fourth nucleic acid comprises SEQ ID NO:8.

17. The engineered yeast of claim 16 that produces less glycerol than a control strain that does not include the nucleic acids under the same fermentation conditions.

18. A method for producing a bioproduct comprising:
fermenting a liquid media comprising a starch material and the engineered yeast of claim 1 , wherein said fermenting produces the bioproduct.

19. The method of claim 18 wherein the bioproduct is ethanol and fermenting provides at a concentration of 90 g/L or greater in the liquid media.

20. The method of claim 18 wherein the starch material is present in the liquid media at a concentration in the range of 30 to 37 wt % (dry solids) and the starch material has a dextrose equivalent in the range of 45 to 65.

Assignees

• Cargill Inc

Inventors

• Miller Christopher K
• Negrete-Raymond Ana
• Veldhouse Jon
• Vas Amit

Classifications

• C12P7/10

  substrate containing cellulosic material · CPC title

• C12Y302/01003

  Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

• C12N9/2428 Primary

  Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

• C12N15/81 Primary

  for yeasts · CPC title

• C12P7/06

  Ethanol, i.e. non-beverage · CPC title